Please note that following on from information provided to NICE by the company in April 2024, the appraisal was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued.
- Status:
- Discontinued
- Technology type:
- Medicine
- Decision:
- Prioritised
- Process:
- TA
- ID number:
- 4058
Email enquiries
If you have any queries please email scheduling@nice.org.uk
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 22 May 2025 | Discontinued. Please note that following on from information provided to NICE by the company in April 2024, the appraisal was suspended from NICE’s work programme. As no further information has been received from the company the topic has been discontinued. |
| 12 April 2024 | Note - Note added to the project documents |
| 31 March 2023 | Suspended. Following on from information received from the company, NICE has decided to suspend this appraisal from its current work programme. The timelines for this appraisal are to be aligned with the latest regulatory and UK launch expectations and further information regarding the scheduling of this appraisal will be available in due course. |
For further information on our processes and methods, please see our CHTE processes and methods manual